Waltham, Massachusetts Clinical Trials

A listing of Waltham, Massachusetts clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 115 clinical trials
Efficacy of Near-Infrared Vein Imaging for Difficult IV Placement

The objective of this project is to define the effectiveness and therefore the role of NIR vein finders in adult patients with difficult peripheral venous access. The specific objective of the proposed randomized controlled trial is to test the clinical success rate of placing peripheral venous catheters in 'difficult' access …

Lahey Clinic
 (6.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

This study will assess the safety, efficacy, and pharmacokinetics of DS-6157a in participants with advanced gastrointestinal stromal tumors (GIST).

chemotherapeutic agent
neutrophil count
pdgfra d842v
measurable disease
gilbert's syndrome
Dana Farber Cancer Institute
 (8.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate …

covid-19
blood test
Massachusetts General Hospital
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +10 other locations
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

This is a Phase 1 study of JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway mutations, including mutations that cause MAPK pathway hyperactivation.

ras-gef
solid tumor
stage iv nsclc
measurable disease
gilbert's syndrome
Massachusetts General Hospital Cancer Center
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function

This exploratory, open-label clinical study aims to explore the physiologic effects of KB109, a novel glycan, on adult patients with COVID-19 illness on gut microbiota structure and function in the outpatient setting.

Massachusetts General Hospital
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Wellbeing Stress Reduction and Social Cognition

There are many ways to improve wellbeing. This study will compare two 8-week wellbeing training programs. In addition to looking at how well the programs reduce stress and enhance wellbeing, the investigators will also ask questions about how these programs influence cognition and decision making.

MGH
 (9.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study Evaluating JUV DERM VOLUMA XC Injectable Gel for Correction of Temple Hollowing in Adult Participants Over 22 Years Old

The objectives of this study are to evaluate the safety and effectiveness of Juvederm Voluma XC injectable gel in adult participants seeking correction of temple hollowing

Skincare Physicians
 (5.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +14 other locations
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

This is a Phase Ib/II study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).

Dana-Farber Cancer Institute
 (8.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +29 other locations
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B With or Without Inhibitory Antibodies to Factor VIII or IX

Primary Objective: To characterize the long-term safety and tolerability of fitusiran Secondary Objectives: To characterize the long-term efficacy of fitusiran as assessed by the frequency of: Bleeding episodes Spontaneous bleeding episodes Target joint bleeding episodes To characterize the effects of fitusiran on health-related quality of life (HRQOL) measures in participants …

fitusiran
hemarthrosis
hemophilia
haemophilia a
antihemophilic factor
Investigational Site Number 8400011
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +43 other locations
SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"  

Primary Objective: To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD) Secondary Objectives: To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation To continue to assess the …

topical corticosteroid
corticosteroids
sleep disturbances
atopic
dupilumab
Investigational Site Number 8400010
 (8.9 away)
  • 0 views
  • 19 Feb, 2024
  • +41 other locations